Device Trial Radar · NCT04595838
A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral Mucositis
Last checked: Nov 19, 2026Latest source record: Sep 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
176
Actual
Start
Aug 31, 2020
Primary completion
May 18, 2023
Study completion May 18, 2023
Sponsor
- Lead sponsor
- Chemo MouthpieceNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 22, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will compare the use of the Chemo MouthpieceTM device along with best supportive oral care to best supportive oral care alone to rate the effectiveness of Chemo MouthpieceTM in lessening symptoms associated with chemotherapy regimen known to place patients at risk for symptomatic mucositis and, of those, chemotherapy regimens for which ice-based cryotherapy has been demonstrated to have a favorable impact on oral mucositis symptom management. Subjects who are receiving standard chemotherapy regimens will be randomly assigned to receive either study device and oral care ingredients or oral care ingredients only. All subjects will complete daily diaries for the first 14 days of chemotherapy Cycles 1 and 2. Subjects who are assigned to the study device arm will use the device during their chemotherapy infusion in clinic and will continue to use the device at home ,at least twice daily, for the first six (6) days of chemotherapy Cycles 1 and 2. Prior to the first chemotherapy infusion in Cycle 3, all subjects in the study regardless of treatment assignment will have the option of using the Chemo MouthpieceTM for subsequent cycles.
Conditions
- Oral Mucositis
Interventions
Chemo MouthpieceDevice
Frozen tube that fills the oral cavity used during and after chemotherapy to ease and prevent symptoms of oral mucositis
Best Supportive Care onlyOther
Standard Oral care for Chemotherapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidence of oral mucositis symptomatic events observed during the first cycle of chemotherapy.Time frame: Cycle 1 of chemotherapy (14-28 days, time frame varies based on regimen)
- The incidence of oral mucositis symptomatic events observed during the second cycle of chemotherapy.Time frame: Cycle 2 of chemotherapy (14-28 days, time frame varies based on regimen)
- The incidence of severe oral mucositis symptomatic events observed during the first cycle of chemotherapy.Time frame: Cycle 1 of chemotherapy (14-28 days, time frame varies based on regimen)
1 more outcomes with a free account
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Chan Soon-Shiong Institute for Medicine
Costa Mesa, California
Goshen Health
Goshen, Indiana
Revive Research Institute
Farmington Hills, Michigan
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.